Cite
MLA Citation
H. Soifer et al.. “HNSCCs overexpressing wild-type HRAS are sensitive to combined tipifarnib and alpelisib treatment.” European journal of cancer, vol. 174, n.d., pp. S58–. http://access.bl.uk/ark:/81055/vdc_100168600455.0x000037